INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Nachman Shlomo reported ATRC

Director · AtriCure, Inc. · Common Stock

Side
A
Value
—
Shares
6,144
Price
—
Executed
May 18, 2026
Disclosed
May 20, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
May 18 executedMay 20, 2026 disclosed

ATRC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 33.2% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ATRC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    15
    PS
    Privitera SalvatoreChief Technical Officer
    ATRCAtriCure, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$546K
    8,404 sh
    		Nov 4, 2026Nov 5, 2026
    traded Nov 4, 2026
    		+1dSEC FORM 4

    Evidence

    27
    Gilbert Ray Cisneros, Jr.DSelf
    ATRCAtriCure, Inc.
    Partial sale
    		SELL$1,001 – $15KSep 29, 2026Oct 12, 2026
    traded Sep 29, 2026
    		+13dHOUSE PTR

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    ATRCAtriCure, Inc.
    Purchase
    		BUY$1,001 – $15KAug 20, 2026Sep 10, 2026
    traded Aug 20, 2026
    		+21dHOUSE PTR

    Evidence

    31
    DS
    Dahlquist Karl S.Chief Legal Officer
    ATRCAtriCure, Inc.
    Open-market sale
    		SELL$458K
    9,370 sh
    		Aug 24, 2026Aug 26, 2026
    traded Aug 24, 2026
    		+2dSEC FORM 4

    Evidence

    17
    TH
    Telman Deborah HDirector
    ATRCAtriCure, Inc.
    Grant or award
    		A—
    6,144 sh
    		May 18, 2026May 20, 2026
    traded May 18, 2026
    		+2dSEC FORM 4

    Evidence

    28
    Gilbert Ray Cisneros, Jr.DSelf
    ATRCAtriCure, Inc.
    Purchase
    		BUY$1,001 – $15KMar 3, 2026Apr 7, 2026
    traded Mar 3, 2026
    		+35dHOUSE PTR

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002006261-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 18, 2026
    Published
    May 20, 2026
    Ingested by INSIDER
    Nov 5, 03:57 UTC
    Last re-read
    Nov 5, 03:57 UTC

    Extracted facts

    Filer
    Nachman Shlomo
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    AtriCure, Inc.
    Ticker
    ATRC
    Shares
    6,144
    Price per share
    $0
    Execution date (reported)
    May 18, 2026
    Owned after transaction
    24.7K shares
    Days from execution to publication
    2

    What this establishes

    Nachman Shlomo filed this Form 4 reporting a grant or award of ATRC on May 18, 2026. It became public on May 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Nachman Shlomocik:0002006261
    Issuer
    AtriCure, Inc.cik:0001323885

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.